SCHEMBL26836166

SCHEMBL26836166

Cc1cc(C(C)C)ccc1-c1cc2ccccc2c[n+]1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.42
UGT2B7 P16662 1/20 0.37
TRPA1 O75762 1/20 0.34
PTGS1 P23219 1/20 0.34
CACNA1C Q13936 1/20 0.34
AKR1C3 P42330 2/20 0.32
AKR1C2 P52895 2/20 0.32
PDK2 Q15119 1/20 0.32
CYP2D6 P10635 3/20 0.32
HSD17B10 Q99714 1/20 0.32
CYP2A6 P11509 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
MEN1 O00255 1/20 0.31
CYP1A2 P05177 1/20 0.31
TSHR P16473 1/20 0.31
KMT2A Q03164 1/20 0.31
HIF1A Q16665 1/20 0.31
KIF11 P52732 1/20 0.30
CYP3A4 P08684 1/20 0.30
SLC6A2 P23975 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26836165 0.90 LMNA (0.47) LMNAUGT2B7TRPA1PTGS1CACNA1C
SCHEMBL26836027 0.84 LMNA (0.41) LMNAUGT2B7TRPA1PTGS1CACNA1C
SCHEMBL26835925 0.84 LMNA (0.41) LMNAUGT2B7TRPA1PTGS1CACNA1C
SCHEMBL26836323 0.82 LMNA (0.37) LMNATRPA1PTGS1CACNA1C
SCHEMBL25450661 0.81 LMNA (0.47) LMNATRPA1PTGS1CACNA1CAKR1C3
SCHEMBL25639521 0.81 CYP2A6 (0.42) CYP2D6HSD17B10CYP2A6TDP1MEN1
SCHEMBL25450505 0.80 LMNA (0.48) LMNATRPA1PTGS1CACNA1CAKR1C3
SCHEMBL25445421 0.79 PLA2G7 (0.36) TRPA1CYP2D6HSD17B10CYP2A6TDP1
SCHEMBL25518753 0.79 HSD17B10 (0.34) LMNACYP2D6HSD17B10CYP2A6TDP1
SCHEMBL25451690 0.79 LMNA (0.44) LMNATRPA1PTGS1CACNA1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382935-A1 COMPOUND CONTAINING 1,3-DIKETONE LIGAND AND APPLICATION THEREOF, AND ORGANIC ELECTROLUMINESCENT DEVICE BEIJING GREEN GUARDEE TECHNOLOGY CO., LTD. (CN) 2023-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382935-A1 COMPOUND CONTAINING 1,3-DIKETONE LIGAND AND APPLICATION THEREOF, AND ORGANIC ELECTROLUMINESCENT DEVICE TLK1, TLK2, PDK3 LMNA 2429/4885UGT2B7 4165/4885TRPA1 422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.